secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0000950170-25-037885
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma appoints Pasha Sarraf to board of directors
---------------------------------------------------------

- Pasha Sarraf appointed to board on March 10, 2025.
- Granted option to purchase 48,800 shares vesting over three years.
- Compensation per Company's Director Compensation Policy.
- Entered standard indemnification agreement for director service.
- No arrangements or transactions between Sarraf and Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017025037885/0000950170-25-037885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017025037885/cue-20250310.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-037885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer